Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Total Liabilities : $49.10 Mil (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Total Liabilities?

Skystar Bio-Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2014 was $49.10 Mil.

Skystar Bio-Pharmaceutical Co's quarterly Total Liabilities increased from Mar. 2014 ($24.53 Mil) to Jun. 2014 ($43.06 Mil) and increased from Jun. 2014 ($43.06 Mil) to Sep. 2014 ($49.10 Mil).

Skystar Bio-Pharmaceutical Co's annual Total Liabilities increased from Dec. 2011 ($15.77 Mil) to Dec. 2012 ($19.54 Mil) and increased from Dec. 2012 ($19.54 Mil) to Dec. 2013 ($25.83 Mil).

Skystar Bio-Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Total Liabilities Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Total Liabilities

Get a 7-Day Free Trial

6.69

9.76

15.77

19.54

25.83

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Total Liabilities	Get a 7-Day Free Trial															29.39	25.83	24.53	43.06	49.10

Skystar Bio-Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Skystar Bio-Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2013 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.966	+	(0	+	0.061999999999997
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.802	+	0)
	=	25.83

Total Liabilities	=	Total Assets (A: Dec. 2013 )	-	Total Equity (A: Dec. 2013 )
	=	136.223	-	110.393
	=	25.83

Skystar Bio-Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2014 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	48.308	+	(0	+	-6.6613381477509E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.796	+	0)
	=	49.10

Total Liabilities	=	Total Assets (Q: Sep. 2014 )	-	Total Equity (Q: Sep. 2014 )
	=	171.608	-	122.505
	=	49.10

Skystar Bio-Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines